- Forums
- ASX - By Stock
- NUZ
- Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints
Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints, page-37
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $98.34M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $85.16K | 424.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 67508 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 41639 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 47508 | 0.195 |
8 | 279878 | 0.190 |
12 | 723520 | 0.185 |
6 | 377800 | 0.180 |
5 | 151797 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 41639 | 4 |
0.205 | 21529 | 1 |
0.210 | 107676 | 2 |
0.215 | 154400 | 2 |
0.220 | 140000 | 2 |
Last trade - 15.21pm 15/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online